JANX
Janux Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.59
−1.60%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.45
- Revenue estimate
- $8.0M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.25
- Revenue actual
- $10.3M
- Revenue estimate
- $19.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +1.5%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $39
- PT range
- $23 – $55
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.25 | -$0.35 | Miss -39.28% | $10.3M |
| May 7, 2026 | -$0.52 | -$0.39 | Beat 25.03% | $3.7M |
| Nov 6, 2025 | -$0.60 | -$0.39 | Beat 35.00% | $10.0M |
| Aug 7, 2025 | -$0.48 | -$0.55 | Miss -14.58% | — |
| May 8, 2025 | -$0.43 | -$0.38 | Beat 11.63% | — |
| Feb 27, 2025 | -$0.49 | -$0.36 | Beat 26.53% | — |
| Mar 8, 2024 | -$0.37 | -$0.25 | Beat 32.43% | $2.5M |
| Mar 10, 2023 | -$0.45 | -$0.39 | Beat 13.33% | $2.8M |
| Nov 10, 2022 | -$0.51 | -$0.40 | Beat 21.57% | $1.8M |
| Mar 18, 2022 | -$0.30 | -$0.33 | Miss -10.00% | $1.6M |
| Jun 11, 2021 | — | -$0.13 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026